Pathologies and Treatments

Diabetic macular edema is the inflammation and accumulation of fluid in the macula. The macula is the part of the eye responsible for central vision and fine detail vision, such as reading or recognizing faces. It occurs when the blood vessels in the retina leak fluid.

The main cause of macular edema is associated with diabetes. This disease causes the retinal blood vessels to leak fluids. This includes small amounts of blood and, at times, leakage of fat deposits. This situation causes the macula to become inflamed.

Symptoms

Diabetic macular edema shows few symptoms at the beginning, mainly blurred and faded vision, but it must be treated in time to avoid irreversible degenerative changes.

Treatments

The treatment of diabetic macular edema must be individualized for each case, depending on the severity, the specific characteristics of the patient, and the comorbidities that may be associated, both ophthalmologically and systemically. There are various treatment options, such as eye drops, intravitreal injections of anti-VEGF drugs or corticosteroids, focal photocoagulation, or MicroPulse laser. In specific cases, the approach with microsurgery through posterior vitrectomy is also an option.

The most advanced technology available to our patients

The Institut de la Màcula, in its effort to offer patients the best and most innovative treatments, has the most advanced technology to detect cases of diabetic macular edema and to monitor their progression and response to the applied treatment. The Institute uses MicroPulse technology, developed recently, which has shown excellent results in some cases of diabetic macular edema. This technology is a therapy based on a very low-intensity laser source, with short, repetitive microsecond pulses, which is a safe and effective method to treat diabetic macular edema, and in some cases allows avoiding or delaying the use of intravitreal injections.

Medicina regenerativa: Endoret

Con el tratamiento de medicina regenerativa Endoret propiciamos la reparación de la superficie ocular afectada por la sequedad ocular. Se trata de un plasma rico en factores de crecimiento para el tratamiento de las lesiones de la superficie ocular elaborado a partir de la sangre del mismo paciente. Con esta formulación individualizada se consigue una tolerancia completa y una efectividad óptima. Esta opción terapéutica revolucionaria es muy eficaz en casos de defectos epiteliales persistentes o úlceras corneales. Asimismo se puede aplicar después de una cirugía refractiva corneal, una cirugía ocular o en el Síndrome de Sjögren.

Procedures

Medicina regenerativa: Endoret

Con el tratamiento de medicina regenerativa Endoret propiciamos la reparación de la superficie ocular afectada por la sequedad ocular. Se trata de un plasma rico en factores de crecimiento para el tratamiento de las lesiones de la superficie ocular elaborado a partir de la sangre del mismo paciente. Con esta formulación individualizada se consigue una tolerancia completa y una efectividad óptima. Esta opción terapéutica revolucionaria es muy eficaz en casos de defectos epiteliales persistentes o úlceras corneales. Asimismo se puede aplicar después de una cirugía refractiva corneal, una cirugía ocular o en el Síndrome de Sjögren.

Dr. Jordi Monés,

M.D. PhD

Número de Col·legiat COMB: 22.838

Director. Doctor of Medicine and Surgery. Specialist in Ophthalmology. Specialist in Retina, Macula, and Vitreous.

If you found this interesting, feel free to share it here:

Last modified: 26/08/2025
Scroll to Top
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.